Browse 1,747 esophageal cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
There are two main types of esophageal cancer, and in the United States the more common one is now adenocarcinoma, linked to long term acid reflux and a condition called Barrett's esophagus. Because the esophagus stretches easily, symptoms such as trouble swallowing often appear only after the cancer has grown. Outcomes improve most when cancer is found early and treated with combinations, and trials are testing immunotherapy, targeted drugs, and better ways to spot cancer in people with Barrett's esophagus before it develops.
An Integrative Multi-Omic Characterization of Head and Neck Carcinogenesis, Progression and Recurrence
for
Head and Neck Carcinoma
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 18+
Code: NCT06420219
Recruiting
A First-in-Human, Phase 1/2 Study of LAT010 in Patients with Advanced Solid Tumors (LIGHTSPEED-1)
for
Advanced Solid Tumor
Location: Margate FL
Sponsor: Latticon Antibody Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT06277219
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
for
Advanced Solid Tumors, HER2 Mutation
Location: Boston MA, Toronto, Fort Myers FL, Cleveland OH,
Sponsor: Bayer
Sex: All
Age: 18+
Code: NCT06760819
Phase 2, Recruiting
Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies
for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 0+
Code: NCT05108519
Recruiting
Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Boston MA, New York NY, Houston TX, Irving TX,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT06167317
Phase 1, Recruiting
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
for
Brain Metastases, Solid Tumors
Location: Boston MA, New York city NY, Pittsburgh PA
Sponsor: Aposense Ltd.
Sex: All
Age: 18+
Code: NCT00805636
Phase 2, Recruiting
A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors
for
Solid Tumor
Location: Boston MA, Fairfax VA, Grand Rapids MI, San Antonio TX,
Sponsor: PAQ Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06797336
Phase 1, Recruiting
Neurodevelopmental Outcomes and Growth in Infants With Congenital Gastrointestinal Anomalies Requiring Neonatal Surgery
for
Gastrointestinal Disease
Location: Minneapolis MN
Sponsor: Children's Hospitals and Clinics of Minnesota
Sex: All
Age: 0
Code: NCT04575649
Recruiting
Vit D3 and Omega 3 in Chemo Induced Neuropathy
for
Cancer, Neuropathy
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Sex: All
Age: 18+
Code: NCT02294149
Phase 3, Recruiting
Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
for
Recurrent or Refractory Solid Tumors, Ewing Sarcoma,
Location: Cincinnati OH, Milwaukee WI, Dallas TX,
Sponsor: South Plains Oncology Consortium
Sex: All
Age: 1 - 20
Code: NCT02013336
Phase 1, Recruiting
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors